ISV-303: Clinical Trials

1 trial of ISV-303, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 11Completed 1
Phase 21Completed 1

Follow ISV-303: new trials by email Literature Review of ISV-303 trials Research Report on ISV-303

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study to Compare Differing Dosing Regimens of ISV-303 (Bromfenac in DuraSite) to Xibrom and Vehicle in Post Cataract Surgery Volunteers
ISV-303, DuraSite Vehicle, Xibromâ„¢ - Ocular Inflammation
Phase 1 / Phase 2CompletedSun Pharmaceutical Industries Limited1692010-08-012021-11-19

Sponsors

Sun Pharmaceutical Industries Limited (1)

Results publications

PMID 28819932